| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Intellia Therapeutics, Inc. | Director | Common Stock | 7,291 | $214,210 | $29.38 | 14 Jun 2022 | Direct |
| Spero Therapeutics, Inc. | Director | Stock Option (right to buy) | 7,500 | $8,400 | $1.12 | 17 Aug 2021 | Direct |
| Ikena Oncology, Inc. | Director | Stock Option (Right to Buy) | 17,520 | 07 Jun 2024 | Direct | ||
| Intellia Therapeutics, Inc. | Director | Stock Option (right to buy) | 7,688 | 14 Jun 2022 | Direct | ||
| Korro Bio, Inc. | Director | Stock Option (Right to Buy) | 6,010 | 11 Jun 2025 | Direct | ||
| Translate Bio, Inc. | Director | Common Stock | 0 | $38.00 | 14 Sep 2021 | Indirect | |
| Translate Bio, Inc. | Director | Stock Option (right to buy) | 0 | 14 Sep 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| KRRO | Korro Bio, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Director | 12 Jun 2025, 16:23 |
| KRRO | Korro Bio, Inc. | 11 Jun 2024 | 1 | $0 | 4 | Director | 12 Jun 2024, 17:25 |
| IKNA | Ikena Oncology, Inc. | 07 Jun 2024 | 1 | $0 | 4 | Director | 10 Jun 2024, 16:15 |
| KRRO | Korro Bio, Inc. | 22 Apr 2024 | 1 | +$999,992 | 4 | Director | 23 Apr 2024, 17:25 |
| KRRO | Korro Bio, Inc. | 03 Nov 2023 | 3 | $0 | 4 | Director | 07 Nov 2023, 21:09 |
| KRRO | Korro Bio, Inc. | 03 Nov 2023 | 0 | $0 | 3 | Director | 07 Nov 2023, 20:54 |
| IKNA | Ikena Oncology, Inc. | 09 Jun 2023 | 1 | $0 | 4 | Director | 13 Jun 2023, 16:30 |
| NTLA | Intellia Therapeutics, Inc. | 14 Jun 2022 | 2 | $0 | 4 | Director | 16 Jun 2022, 18:33 |
| IKNA | Ikena Oncology, Inc. | 09 Jun 2022 | 1 | $0 | 4 | Director | 13 Jun 2022, 18:08 |
| IKNA | Ikena Oncology, Inc. | 21 Dec 2021 | 1 | $0 | 4 | Director | 23 Dec 2021, 17:43 |
| /report/000120919121056045-formela-jean-francois-2021-09-14 | Translate Bio, Inc. | 14 Sep 2021 | 5 | -$78,092,394 | 4 | Director | 14 Sep 2021, 19:23 |
| SPRO | Spero Therapeutics, Inc. | 17 Aug 2021 | 1 | $0 | 4 | Director | 18 Aug 2021, 16:41 |
| NTLA | Intellia Therapeutics, Inc. | 28 Jun 2021 | 18 | -$73,448,879 | 4 | Director | 29 Jun 2021, 09:48 |
| NTLA | Intellia Therapeutics, Inc. | 23 Jun 2021 | 2 | $0 | 4 | Director | 25 Jun 2021, 18:05 |
| /report/000120919121041811-formela-jean-francois-2021-06-16 | Translate Bio, Inc. | 16 Jun 2021 | 1 | $0 | 4 | Director | 17 Jun 2021, 21:39 |
| NTLA | Intellia Therapeutics, Inc. | 11 Jun 2021 | 7 | -$17,558,774 | 4 | Director | 15 Jun 2021, 09:51 |
| IKNA | Ikena Oncology, Inc. | 30 Mar 2021 | 4 | +$1,614,428 | 4 | Director | 14 Dec 2021, 19:29 |